Nurse Practitioner · Rochester, MN
NPI
1003225244
Since 2014
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
200 1st St SW
Rochester, MN, 55905
Phone (507) 284-2511
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
469 services
Medicare patients, 2024
249
Average age 75
Drug cost, 2024
$3.2M
403 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy Behnken was code 99215 (office e&m - established), 176 times for 140 patients. In total Amy Behnken billed 469 services in 8 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 176 | 140 | $111.54 | $20K |
| 99214 Office E&M - Established | Office | 143 | 122 | $80.25 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 80 | 60 | $10.90 | $872 |
| 99213 Office E&M - Established | Office | 25 | 23 | $55.92 | $1,398 |
| 99442 Telephone Services | Office | 24 | 21 | $56.68 | $1,360 |
| 99443 Telephone Services | Office | 16 | 16 | $85.32 | $1,365 |
By year: 2022 $35K for 335 services; 2023 $37K for 380 services; 2024 $36K for 469 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy Behnken prescribed most often to Medicare patients was Venclexta (Venetoclax), with 108 prescriptions and refills. In total Amy Behnken wrote 403 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venclexta Venetoclax | 108 | 108 | 15 | $1.5M |
| Calquence Acalabrutinib Maleate | 70 | 70 | 12 | $707K |
| Imbruvica Ibrutinib | 69 | 69 | Under 11 | $707K |
| Acyclovir Generic | 50 | 128 | 17 | $1,270 |
| Brukinsa Zanubrutinib | 22 | 22 | Under 11 | $184K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 50 | Under 11 | $306 |
| Allopurinol Generic | 13 | 15 | Under 11 | $50.13 |
Brand drugs: 283 claims; generic drugs: 120 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Amy Behnken were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.